Table I.
Expression of differential antigens in 35 patients with acute lymphoblastic leukemia [n (%)].
| Types | n | CD2 | CD3 | CD7 | CD19 | CD20 | CD22 |
|---|---|---|---|---|---|---|---|
| B-ALL | 22 | 0 | 1 (4.5) | 0 | 22 (100) | 9 (40.9) | 14 (63.6) |
| T-ALL | 13 | 9 (69.2) | 10 (76.9) | 13 (100) | 0 | 0 | 0 |
| Total | 35 | 9 (25.7) | 11 (31.4) | 13 (37.1) | 22 (62.9) | 9 (25.7) | 14 (40.0) |
| Types | n | CD13 | CD14 | CD33 | CD117 | HLA-DR | CD34 |
| B-ALL | 22 | 5 (22.7) | 0 | 2 (9.1) | 0 | 21 (95.5) | 19 (86.4) |
| T-ALL | 13 | 0 | 1 (7.7) | 2 (15.4) | 3 (23.1) | 7 (53.8) | 6 (46.2) |
| Total | 35 | 5 (14.3) | 1 (2.9) | 4 (11.4) | 3 (8.6) | 28 (80.0) | 25 (71.4) |
B-ALL, B cell acute lymphoblastic leukemia; T-ALL, T cell acute lymphoblastic leukemia.